Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shot up 3.6% during mid-day trading on Thursday . The company traded as high as $24.05 and last traded at $23.86. 59,742 shares traded hands during trading, a decline of 62% from the average session volume of 159,164 shares. The stock had previously closed at $23.02. Wall […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,190,000 shares, an increase of 16.5% from the April 30th total of 1,880,000 shares. Based on an average daily trading volume, of 167,500 shares, the short-interest […]
Wedbush reiterated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Wedbush currently has a $41.00 price target on the stock. Other analysts also recently issued reports about the stock. Jefferies Financial Group initiated coverage on shares of Aerovate Therapeutics in […]
Wedbush restated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a $41.00 price target on the stock. AVTE has been the subject of a number of other reports. Wells Fargo & Company reissued an overweight rating and […]